The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers-Reference-Cited by-同舟云学术

The results of SGLT-2 inhibitors use in kidney transplantation: 1-year experiences from two centers

Published:2023-06-08 Issue:11 Volume:55 Page:2989-2999
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Demir Mehmet Emin,Özler Tuba Elif,Merhametsiz Özgür,Sözener Ulaş,Uyar Murathan,Ercan Zafer,Bardak Demir Simge^ORCID,Sezer Siren,Türkmen Sarıyıldız Gülçin

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-023-03645-7.pdf

Reference35 articles.

1. SLC5A2 solute carrier family 5 member 2 [Homo sapiens (human)] (2022). https://www.ncbi.nlm.nih.gov/gene/6524. Accessed 1 Dec 2022

2. Kanai Y, Lee WS, You G, Brown D, Hediger MA (1994) The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 93(1):397–404. https://doi.org/10.1172/JCI116972

3. Gyimesi G, Pujol-Giménez J, Kanai Y, Hediger MA (2020) Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application. Pflugers Arch 472(9):1177–1206. https://doi.org/10.1007/s00424-020-02433-x

4. Wright EM (2021) SGLT2 inhibitors: physiology and pharmacology. Kidney360. 2(12):2027–2037. https://doi.org/10.34067/KID.0002772021

5. Teo YH, Teo YN, Syn NL, Kow CS, Yoong CSY, Tan BYQ, Yeo TC, Lee CH, Lin W, Sia CH (2021) Effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors on cardiovascular and metabolic outcomes in patients without diabetes mellitus: a systematic review and meta-analysis of randomized-controlled trials. J Am Heart Assoc 10(5):e019463. https://doi.org/10.1161/JAHA.120.019463

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05-21